News

Researchers have discovered a set of biomarkers that can be used to predict which patients diagnosed with glioblastoma may have tumors that are more resistant to radiation therapy. The discovery could inform treatment decisions that should enable patients to live longer.

A CRISPR screening tool has been used to identify a new therapeutic target to treat acute myeloid leukemia (AML) that may have fewer side effects than current approaches.

A collaborative team of researchers, including CRISPR pioneer Feng Zhang, have developed a novel system known as SEND that harnesses human proteins to deliver molecular therapies.

In the United States, the early COVID-19 vaccination campaign prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May.

Researchers have found that amounts of some medications carried by a stream in Baltimore were substantial, despite generally low concentrations over the course of a year.

Additional COVID-19 vaccine doses will soon be available in the U.S. to provide added protection against the coronavirus. But who is eligible for a third dose? And what can you expect if you need one?

The National Institute of Health and Care Excellence (NICE) has approved the use of a new drug combo – abemaciclib (Verzenios) and fulvestrant (Faslodex) – for some adults with an advanced form of breast cancer that’s spread to other parts of the body.

A team of researchers is expanding the precision and ability of CAR T-cell therapy in order to target solid tumors.

A team of researchers from Tel Aviv University has 3D-printed a first-of-its-kind glioblastoma tumor that could be used to improve treatment and accelerate the development of novel drugs.

The role of nasal bacteria in the induction of virus-specific adaptive immunity is not clear. New research explores the role of nasal bacteria and provides clues to developing better intranasal vaccines for flu and COVID-19.